Specializes in high precision radiation techniques including IMRT, IGRT, Rapid Arc and SBRT. His advanced training and specialized expertise enable him to deliver personalized and cutting-edge cancer care, ensuring best possible outcomes and improved quality of life for his patients.

• Member – Fellow of the Royal College of Radiologists (FRCR) – Clinical Oncology.
• Member – Federation of Asian Radiation Oncologists (FARO).
• AROI – Life time Member – Association of Radiation Oncologists of India.
• ICRO – Life time Member – Indian College of Radiation Oncology.
• IBS – Life time Member – Indian Brachytherapy Society.
• YROC – Life time Member – Young Radiation Oncologists Club of India.
• ISO – Life time Member – Indian Society of Oncologists.

• Presented his phase II study ” Capecitabine based chemoradiation in Cisplatin ineligible patients of locally advanced carcinoma uterine cervix” as Guest orator in Federation of Asian Radiation Oncologists Conference at Seoul, South Korea in October
• Best Doctor award – for serving tribal areas 2018, awarded by District administration in Tamil Nadu, India.
• Bhoopal Award – Best poster presentation in Association of Radiation Oncologists of India, Tamil Nadu Chapter Conference– 2019.
• Gold Medal in Oncology Quiz – Association of Radiation Oncologists of India, Tamil Nadu Chapter Conference – 2022
• First place in Oral presentation (Clinical) in 2nd Global Cancer Consortium conference, Conducted by MAHE, Manipal, Karnataka in association with Kentucky Cancer Centre & Markey Cancer Centre, US in January 2023
• Best poster presentation in Max National Congress, New Delhi, India – April
• Best Outgoing student – MD (Radiation Oncology) at Cancer Institute (WIA), Adyar, Chennai (2019 batch)

• Capecitabine as a radiosensitizer in Locally advanced carcinoma of uterine cervix – Prospective phase II study
• HYPOTRAX CRT Study – Adjuvant concurrent chemoradiation with Taxol+/- trastuzumab along with Hypo fractionated versus Standard fractionated postmastectomy radiotherapy – phase II Study
• Thyroid gland as Organ at risk (OAR) in Contouring regional nodal irradiation in postmastectomy in patients – Prospective Pilot study.